|
Market Closed -
CBOE
20:59:45 13/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 33.44 USD | -3.30% |
|
0.00% | - |
| 3 months | +2.73% | ||
| 6 months | +13.13% |
Main features
| US46138G5999 | Fees | 0.19% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (GBP) | 68.3M | Replication Method | Direct (Physical) |
| Number of securities | 248 | AuM evolution | - | Date of creation | 08/06/2021 |
| Name |
Off-Hours Price |
Change |
Weight | |
|---|---|---|---|---|
 | 485.22USD | -4.30% | 8.54% | |
| 147.92USD | -1.67% | 7.99% | |
| 412.84USD | -1.13% | 7.76% | |
| 753.12USD | -1.27% | 6% | |
| 155.82USD | -1.59% | 4.05% | |
| 223.82USD | -1.41% | 3.94% | |
| 96.79USD | -1.80% | 2.79% | |
| 228.90USD | -0.22% | 1.94% | |
| 802.64USD | -1.19% | 1.83% | |
| 543.40USD | -1.22% | 1.6% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Biotechnology, Pharmaceuticals |
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
| Date | Price | Change |
|---|---|---|
| 13/10/26 | US$33.44 | -3.30% |
| 09/10/26 | US$34.58 | - |
| 08/10/26 | US$0.000000 | -100.00% |
| 07/10/26 | US$34.01 | - |
Similar ETF
| Fees | |
|---|---|
 iShares Biotechnology ETF - USD(IBB) | 0.44% |
- Stock Market
- ETF
- IBBQ ETF
Select your edition
All financial news and data tailored to specific country editions
